2013
DOI: 10.7897/2230-8407.04645
|View full text |Cite
|
Sign up to set email alerts
|

Development and Validation of Uv Spectrophotometric Estimation of Ebastine in Bulk and Tablet Dosage Form Using Area Under Curve Method

Abstract: The aim of this work is to develop a simple, accurate, reproducible and cost effective spectrophotometric method for determination of Ebastine in bulk and pharmaceutical dosage form. This method is basedon area under curve (AUC) in wavelength range of 247-257nm and method has followed linearity in the concentration range of 5-30μg/ml. Methanol was used as a solvent. The developed analytical method was validated as per International Conference on Harmonization (ICH) guidelines. The value of correlation coeffici… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 3 publications
0
5
0
Order By: Relevance
“…On the other hand, it may be used to analyze the possible impact of formulation and manufacturing factors on the biopharmaceutical characteristics of the tablet, as well as a quality control tool to evaluate consistency. [16][17][18][19][20][21][22][23]…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, it may be used to analyze the possible impact of formulation and manufacturing factors on the biopharmaceutical characteristics of the tablet, as well as a quality control tool to evaluate consistency. [16][17][18][19][20][21][22][23]…”
Section: Discussionmentioning
confidence: 99%
“…This wavelength range is selected from area under curve vs. concentration. The area under the curve for first and second derivative are depended on the following theoretical equations 16,17,18…”
Section: Methodsmentioning
confidence: 99%
“…A simple, accurate UV-Visible double beam spectrophotometric method was developed by Jadhav PB et al, 56 for the estimation of bosutinib in bulk and tablet dosage form. A simple, precise UV-Visible double beam spectrophotometer was introduced by Chaitanya G et al, 57 for the determination of nilotinib hydrochloride in bulk and capsule dosage form at 263 ± 0.2 nm.…”
Section: Fig 2: Mechanism Of Tyrosine Kinase Inhibitorsmentioning
confidence: 99%